One-Year Late Lumen Loss between A Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) and a Polymer-Free Paclitaxel-Coated Stent (Zilver PTX) for Femoropopliteal Disease-Reference-Cited by-同舟云学术

One-Year Late Lumen Loss between A Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) and a Polymer-Free Paclitaxel-Coated Stent (Zilver PTX) for Femoropopliteal Disease

Published:2020-02-01 Issue:2 Volume:27 Page:164-171
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Soga Yoshimitsu¹,Fujihara Masahiko²,Tomoi Yusuke¹,Iida Osamu³,Ishihara Takayuki³,Kawasaki Daizo⁴,Ando Kenji¹

Affiliation:

1. Kokura Memorial Hospital, Department of Cardiology

2. Kishiwada Tokushukai Hospital, Department of Cardiology

3. Kansai Rosai Hospital, Cardiovascular center

4. Morinomiya Hospital, Department of Cardiology

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/27/2/27_50369/_pdf

Reference16 articles.

1. 1) Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg, 2007; 45: S5A-S67A

2. 2) Kasapis C, Henke PK, Chetcuti SJ, Koenig GC, Rectenwald JE, Krishnamurthy VN, Grossman PM, Gurm HS. Routine stent implantation vs percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J, 2009; 30: 44-55

3. 3) Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med, 2006; 354: 1879-1888

4. 4) Krankenberg H, Schlüter M, Steinkamp HJ, Bürgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tübler T, Zeller T. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10cm in length: the femoral artery stenting trial (FAST). Circulation, 2007; 116: 285-292

5. 5) Bosiers M, Torsello G, Gissler HM, Ruef J, Müller-Hülsbeck S, Jahnke T, Peeters P, Daenens K, Lammer J, Schroë H, Mathias K, Koppensteiner R, Vermassen F, Scheinert D. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of DURABILITY I study. J Endovasc Ther, 2009; 16: 261-269

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Statin Therapy in Patients Treated with Drug-Eluting and Drug- Coated Stents for Femoropopliteal Lesions: STAR-FP Study Outcomes;2024-09-07

2. Interventional treatment of PAD: Drug-coated balloons and stents;Pathophysiology and Treatment of Atherosclerotic Disease in Peripheral Arteries;2024

3. Progress in the Treatment of Diabetic Foot Vascular Disease;Advances in Clinical Medicine;2024

4. Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries;PLOS ONE;2023-09-21

5. Re-analysis of Old Data and New Outcomes Data Do Not Support a Link Between Paclitaxel Coated Balloons and Paclitaxel Eluting Stents and Mortality: These Devices Should be Used in PAD (Peripheral Arterial Disease) Treatment in Femoropopliteal Disease on the Basis of Their Published Efficacy;CardioVascular and Interventional Radiology;2023-07-12